Filing search / Precipio Inc / "Purpose" / Page 6

S-8

oisacmkfd

30 Mar 23

Registration of securities for employees

4:59pm

8-K

EX-10.2

l6lp1

30 Jun 17

Entry into a Material Definitive Agreement

12:00am

8-K

EX-3.1

0h4xpz8u95um91ls

30 Jun 17

Precipio Diagnostics and Transgenomic Complete Merger

12:00am

S-1

EX-10.6

qkl9oq

10 Mar 00

IPO registration

12:00am

8-K

vsimc wlfo

16 Oct 18

Precipio Announces Third Quarter 2018 Revenues Estimated to be 2.4 Times Third Quarter of 2017 Revenues

4:41pm

8-K

jxyxk

18 Jul 18

Precipio Announces 213% Year-over-Year Revenue Growth in Preliminary Q2-2018 Results

4:50pm

8-K

EX-3.2

opc36

6 Mar 14

Transgenomic Announces $7 Million Convertible Preferred Stock Financing

12:00am

8-K

cfm3wzru0 pupfz5ft

14 May 18

Growth resulting from commercial team reorganization, product and service cross-selling, and increased business stabilization

4:11pm

8-K

95mxs

14 Feb 19

Results of Operations and Financial Condition

12:00am

8-K

EX-10.1

wc1etq rx0ykdyc4efg

3 Nov 17

Precipio, Inc. Announces Pricing of $2,748,000 Registered Direct Offering

12:00am